|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3839404142434445464748...110111» |
- Enrollment open: CASSIS: Cervical And Self-Sample In Screening Study (clinicaltrials.gov) - Sep 28, 2015
P=N/A, N=1000, Recruiting, Sponsor: McGill University
Not yet recruiting --> Recruiting
- |||| somatropin / Generic mfg.
Trial completion, Enrollment change: Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome (clinicaltrials.gov) - Sep 26, 2015
P4, N=69, Completed, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Recruiting --> Completed | N=88 --> 69
- Biomarker, Trial primary completion date: Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism (clinicaltrials.gov) - Sep 25, 2015
P4, N=300, Recruiting, Sponsor: Medical University of Graz
Recruiting --> Completed | N=88 --> 69 Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion, Trial primary completion date: KinKeeper: Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=516, Completed, Sponsor: Michigan State University
Trial primary completion date: Jul 2015 --> Jul 2016 Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Feb 2015
- || Trial primary completion date: Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=60, Recruiting, Sponsor: Lesaffre International
Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Feb 2015 Trial primary completion date: Jun 2015 --> Dec 2015
- || Lynparza (olaparib) / Merck (MSD), AstraZeneca
Trial primary completion date, HEOR, Real-world evidence, BRCA Biomarker, Real-world: OSCA - Olaparib Standard of CAre Study (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=2000, Recruiting, Sponsor: AstraZeneca
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jul 2015 --> Oct 2015
- Trial primary completion date: Screening for Endometrial Abnormalities in Overweight and Obese Women (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=300, Recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Jul 2015 --> Oct 2015 Trial primary completion date: Aug 2015 --> Sep 2016
- Follistim AQ Cartridge (follitropin beta) / Organon
Trial primary completion date: Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles (clinicaltrials.gov) - Sep 25, 2015
P2/3, N=200, Recruiting, Sponsor: National and Kapodistrian University of Athens
Trial primary completion date: Aug 2015 --> Sep 2016 Trial primary completion date: Jan 2015 --> Dec 2015
- Preclinical, Trial primary completion date: Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients (clinicaltrials.gov) - Sep 25, 2015
P3, N=280, Active, not recruiting, Sponsor: KK Women's and Children's Hospital
Trial primary completion date: Jan 2015 --> Dec 2015 Trial primary completion date: Sep 2014 --> Dec 2015
- cabergoline / Generic mfg.
Biomarker, Trial primary completion date: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers (clinicaltrials.gov) - Sep 25, 2015
P3, N=540, Active, not recruiting, Sponsor: KK Women's and Children's Hospital
Trial primary completion date: Sep 2014 --> Dec 2015 Trial primary completion date: Jul 2014 --> Dec 2015
- Trial completion: Evaluation of the Effectiveness of the POWER Through Choices Program (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=1039, Completed, Sponsor: Mathematica Policy Research, Inc.
Trial primary completion date: Jul 2014 --> Dec 2015 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date, HEOR: Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=28, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Apr 2014
- Norditropin (somatropin) / Novo Nordisk
Trial primary completion date: Long Protocol and Growth Hormone in Poor Responders (clinicaltrials.gov) - Sep 24, 2015
P2, N=150, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Apr 2014 Trial primary completion date: Jun 2015 --> Nov 2015
- Trial primary completion date: VIVROVAIRE 2: Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=120, Recruiting, Sponsor: Centre Francois Baclesse
Trial primary completion date: Jun 2015 --> Nov 2015 Trial primary completion date: Dec 2015 --> Jun 2016
- || pimasertib (AS703026) / Day One Biopharma
Trial primary completion date: EMR 200066_012: Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer (clinicaltrials.gov) - Sep 24, 2015
P2, N=65, Active, not recruiting, Sponsor: EMD Serono
Trial primary completion date: Dec 2015 --> Jun 2016 Trial primary completion date: May 2016 --> May 2015
- Trial primary completion date: Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=346, Recruiting, Sponsor: IVI Madrid
Trial primary completion date: May 2016 --> May 2015 Trial primary completion date: Dec 2013 --> Dec 2016
- metformin / Generic mfg.
Trial primary completion date: Metformin for the Treatment of Endometrial Hyperplasia (clinicaltrials.gov) - Sep 24, 2015
P0, N=15, Recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Trial primary completion date: Dec 2013 --> Dec 2016 Trial primary completion date: Dec 2014 --> Dec 2016
- |||| trebananib (AMG 386) / Amgen
Trial primary completion date, Combination therapy: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer (clinicaltrials.gov) - Sep 24, 2015
P3, N=1015, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: May 2016 --> Sep 2015
- veliparib (ABT-888) / AbbVie
Trial primary completion date, Monotherapy, BRCA Biomarker, PARP Biomarker: Veli-BRCA: Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation (clinicaltrials.gov) - Sep 24, 2015
P1/2, N=49, Active, not recruiting, Sponsor: Vejle Hospital
Trial primary completion date: May 2016 --> Sep 2015 Trial primary completion date: Aug 2015 --> Feb 2016
- Taltorvic (ridaforolimus) / Takeda, Merck (MSD)
Trial primary completion date: Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids (clinicaltrials.gov) - Sep 24, 2015
P1, N=24, Active, not recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Trial primary completion date: Aug 2015 --> Feb 2016 Trial primary completion date: Dec 2015 --> Apr 2016
- Avastin (bevacizumab) / Roche
Trial primary completion date: Bevacizumab and Carboplatin for Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 24, 2015
P2, N=30, Active, not recruiting, Sponsor: Vejle Hospital
Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: Aug 2015 --> Feb 2016
- | Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion, Trial primary completion date, IO biomarker: Evaluation of Long Term Immunity Following HPV Vaccination (clinicaltrials.gov) - Sep 24, 2015
P2/3, N=200, Completed, Sponsor: Murdoch Childrens Research Institute
Trial primary completion date: Aug 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Feb 2017 --> Mar 2015
- ||| New trial: HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=3500, Recruiting, Sponsor: Regenstrief Institute, Inc.
- Trial completion: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin (clinicaltrials.gov) - Sep 21, 2015
P2, N=18, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed | Trial primary completion date: Feb 2017 --> Mar 2015 Active, not recruiting --> Completed
- Iclusig (ponatinib) / Takeda, Otsuka
Trial initiation date, Trial primary completion date: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma (clinicaltrials.gov) - Sep 21, 2015
P=N/A, N=15, Not yet recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Initiation date: Aug 2015 --> Jan 2016 | Trial primary completion date: Feb 2016 --> Jul 2018
- | Kombiglyze XR (saxagliptin/metformin XR) / AstraZeneca
Enrollment closed, Monotherapy: BMS-AZPCOS: Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis (clinicaltrials.gov) - Sep 21, 2015
P3, N=36, Active, not recruiting, Sponsor: Woman's
Initiation date: Aug 2015 --> Jan 2016 | Trial primary completion date: Feb 2016 --> Jul 2018 Recruiting --> Active, not recruiting
- ||||| Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
New P4 trial: MEGASET HR: MENOPUR (clinicaltrials.gov) - Sep 18, 2015
P4, N=600, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- Biomarker, New P2 trial, IO biomarker: PAIRHPV: Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (clinicaltrials.gov) - Sep 18, 2015
P2, N=50, Recruiting, Sponsor: Institut Curie
- Enrollment open, IO biomarker: Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology (clinicaltrials.gov) - Sep 17, 2015
P1, N=50, Recruiting, Sponsor: University of Toronto
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment change, Trial termination, Trial primary completion date: Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies (clinicaltrials.gov) - Sep 17, 2015
P=N/A, N=50, Terminated, Sponsor: Sequenom, Inc.
Not yet recruiting --> Recruiting N=1000 --> 50 | Recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Sep 2015; Slow enrollment of eligible subjects
- ||| New trial: Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (clinicaltrials.gov) - Sep 17, 2015
P=N/A, N=200, Not yet recruiting, Sponsor: Institute of Tropical Medicine, Belgium
- Trial initiation date, Trial primary completion date: Natural Cycle Versus Endometrial Preparation for Healthy Blastocyst Transfer (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=236, Completed, Sponsor: European Hospital
N=1000 --> 50 | Recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Sep 2015; Slow enrollment of eligible subjects Initiation date: Jan 2013 --> Feb 2015 | Trial primary completion date: Sep 2014 --> Jul 2015
- |||||| Enrollment open: PRISM: Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis (clinicaltrials.gov) - Sep 16, 2015
P3, N=650, Recruiting, Sponsor: Laboratoire Innotech International
Initiation date: Jan 2013 --> Feb 2015 | Trial primary completion date: Sep 2014 --> Jul 2015 Not yet recruiting --> Recruiting
- New trial: Testosterone Gel in Poor Responders Undergoing IVF (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=120, Not yet recruiting, Sponsor: Vietnam National University
- ||| New trial: HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=647, Completed, Sponsor: Regenstrief Institute, Inc.
- New trial: The Application of Probe-based Confocal Laser Endomicroscopy in the Diagnosis of Deep Endometriosis (clinicaltrials.gov) - Sep 14, 2015
P=N/A, N=10, Not yet recruiting, Sponsor: Dr. Ofir Harnoy MD
- | Biomarker, New P4 trial: To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients. (clinicaltrials.gov) - Sep 14, 2015
P4, N=300, Recruiting, Sponsor: KK Women's and Children's Hospital
- ||| New trial: Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine (clinicaltrials.gov) - Sep 14, 2015
P0, N=598, Not yet recruiting, Sponsor: Regenstrief Institute, Inc.
- Trial completion: Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis (clinicaltrials.gov) - Sep 10, 2015
P=N/A, N=30, Completed, Sponsor: University of Cagliari
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| anastrozole/levonorgestrel (BAY 98-7196) / Bayer
New P1 trial: Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring (clinicaltrials.gov) - Sep 10, 2015
P1, N=52, Not yet recruiting, Sponsor: Bayer
- Preclinical, Trial primary completion date: Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation (clinicaltrials.gov) - Sep 10, 2015
P1/2, N=50, Recruiting, Sponsor: National and Kapodistrian University of Athens
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Dec 2015
- Preclinical, Trial primary completion date: Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation (clinicaltrials.gov) - Sep 10, 2015
P2/3, N=100, Recruiting, Sponsor: National and Kapodistrian University of Athens
Trial primary completion date: Jan 2015 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- |||| Trial completion: Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus (clinicaltrials.gov) - Sep 10, 2015
P2, N=56, Completed, Sponsor: Deana Funaro
Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed
- Votrient (pazopanib) / Novartis, BeiGene
Enrollment closed, Combination therapy: PAZPET-1: [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (clinicaltrials.gov) - Sep 9, 2015
P1, N=17, Active, not recruiting, Sponsor: Imperial College London
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono
Trial completion, Trial primary completion date: Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (clinicaltrials.gov) - Sep 9, 2015
P3, N=941, Completed, Sponsor: Merck KGaA
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015
- amlodipine besilate / Generic mfg., clomifene citrate / Generic mfg.
New trial: Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients (clinicaltrials.gov) - Sep 9, 2015
P=N/A, N=60, Completed, Sponsor: Ahmed Fathy Ali Mohamed Ghanem
- |||| trebananib (AMG 386) / Amgen
Trial primary completion date: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) - Sep 8, 2015
P3, N=223, Active, not recruiting, Sponsor: Amgen
Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015 Trial primary completion date: Nov 2014 --> Aug 2014
- |||| trebananib (AMG 386) / Amgen
Trial primary completion date, Combination therapy: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer (clinicaltrials.gov) - Sep 8, 2015
P3, N=919, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: Nov 2014 --> Aug 2014 Trial primary completion date: Jun 2013 --> Mar 2013
- || New P3 trial: Does Endometrial Injury Improve Intrauterine Insemination Outcome? (clinicaltrials.gov) - Sep 8, 2015
P3, N=352, Active, not recruiting, Sponsor: Ain Shams Maternity Hospital
- New trial: PVD/tDCS: Efficacy of Transcranial Direct-Current Stimulation (tDCS) for Provoked Vestibulodynia : a Triple Blind Randomized Controlled Trial (clinicaltrials.gov) - Sep 8, 2015
P=N/A, N=40, Recruiting, Sponsor: Universit